Patients' Preferences for the Treatment of Moderate to Severe Rheumatoid Arthritis

被引：0
|
作者：
Hauber, A. Brett [1 ]
Poulos, Christine [1 ]
Gonzalez, Juan Marcos [1 ]
Ogale, Sarika [2 ]
Moawad, Dalia [2 ]
Turpcu, Adam [2 ]
机构：
[1] RTI Hlth Solut, Res Triangle Pk, NC USA
[2] Genentech Inc, San Francisco, CA 94080 USA
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
453
引用
收藏
页码：S173 / S173
页数：1
相关论文
共 50 条
  • [1] TOFACITINIB FOR THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS
    de Lartigue, J.
    [J]. DRUGS OF TODAY, 2012, 48 (08) : 533 - 543
  • [2] Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden
    Bansback, NJ
    Brennan, A
    Ghatnekar, O
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (07) : 995 - 1002
  • [3] PREFERENCES OF TUNISIAN PATIENTS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
    El Mabrouk, Y.
    Ben Abdelghani, K.
    Miladi, S.
    Fazaa, A.
    Sallemi, M.
    Souebni, L.
    Ouenniche, K.
    Kassab, S.
    Chekili, S.
    Laatar, A.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S376 - S377
  • [4] Better disease activity states are achieved with etanercept treatment in patients with moderate rheumatoid arthritis vs severe rheumatoid arthritis
    Keystone, Edward
    Freundlich, Bruce
    Schiff, Michael
    Li, Juan
    Hooper, Michele
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S531 - S531
  • [5] Cost Effectiveness of Different Treatment Strategies in the Treatment of Patients with Moderate to Severe Rheumatoid Arthritis in China
    Wu, Bin
    Wilson, Alisa
    Wang, Fang-fang
    Wang, Su-li
    Wallace, Daniel J.
    Weisman, Michael H.
    Lu, Liang-jing
    [J]. PLOS ONE, 2012, 7 (10):
  • [6] Abatacept: A novel treatment for moderate-to-severe rheumatoid arthritis
    Reynolds, Jennifer
    Shojania, Kam
    Marra, Carlo A.
    [J]. PHARMACOTHERAPY, 2007, 27 (12): : 1693 - 1701
  • [7] Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis
    Hushaw, Linda L.
    Sawaqed, Ray
    Sweis, Ghaleb
    Reigle, Jori
    Gopal, Anjali
    Brandt, Daniel
    Sweis, Nadia
    Curran, James
    Niewold, Timothy B.
    Sweiss, Nadera J.
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 143 - 152
  • [8] Treatment of moderate rheumatoid arthritis
    McKenna, Frank
    [J]. RHEUMATOLOGY, 2022, 61 (02) : 478 - 479
  • [9] Cost effectiveness of adalimumab (HUMIRA™, Abbott) in the treatment of patients with moderate to severe rheumatoid arthritis (RA)
    Bansback, NJ
    Brennan, A
    Sengupta, N
    Chang, KY
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S215 - S215
  • [10] Comparison of efficacy responses to etanercept treatment in rheumatoid arthritis patients with moderate versus severe disease
    Keystone, E
    Chon, Y
    Eickenhorst, T
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 180 - 180
12345